Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor

Cancer Research

Volumn 63, Issue 6, 2003, Pages 1166-1171

  Tang, Yucheng ^a   Zhang, Donglei ^a   Fallavollita, Lucia ^a   Brodt, Pnina ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; COMPLEMENTARY DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLALANINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TYROSINE; VASCULOTROPIN C;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LYMPH NODE; LYMPH NODE METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARCINOMA, LEWIS LUNG; CHROMONES; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; FLAVONOIDS; INSULIN-LIKE GROWTH FACTOR I; LYMPHATIC METASTASIS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 0037444268     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Oliver, G., and Detmar, M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev., 16: 773-783, 2000.
2. Karpanen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Yla-Herttuala, S., Jaattela, M., and Alitalo, K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res., 61: 1786-1790, 2001.
3. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N., and Alitalo, K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J., 16: 3898-3911, 1997.
4. Kubo, H., Fujiwara, T., Jussila, L., Hashi, H., Ogawa, M., Shimizu, K., Awane, M., Sakai, Y., Takabayashi, A., Alitalo, K., Yamaoka, Y., and Nishikawa, S. I. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood, 96: 546-553, 2000.
5. Partanen, T. A., Alitalo, K., and Miettinen, M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer (Phila.), 86: 2406-2412, 1999.
6. Enholm, B., Karpanen, T., Jeltsch, M., Kubo, H., Stenback, F., Prevo, R., Jackson, D. G., Yla-Herttuala, S., and Alitalo, K. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res., 88: 623-629, 2001.
7. Veikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T. V., Kubo, H., Thurston, G., McDonald, D. M., Achen, M. G., Stacker, S. A., and Alitalo, K. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J., 20: 1223-1231, 2001.
8. Oh, S. J., Jeltsch, M. M., Birkenhager, R., McCarthy, J. E., Weich, H. A., Christ, B., Alitalo, K., and Wilting, J. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol., 188: 96-109, 1997.
9. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., and Detmar, M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med., 7: 192-198, 2001.
10. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D. G., Orci, L., Alitalo, K., Christofori, G., and Pepper, M. S. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J., 20: 672-682, 2001.
11. Swartz, M. A., and Skobe, M. Lymphatic function. Lymphangiogenesis and cancer metastasis. Microsc. Res. Technique, 55: 92-99, 2001.
12. Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., Munn, L. L., and Jain, R. K. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science (Wash. DC), 296: 1883-1886, 2002.
13. Samani, A. A., and Brodt, P. The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis. Surg. Oncol. Clin. N. Am., 10: 289-312, 2001.
14. r 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Cancer Res., 58: 3243-3247, 1998.
15. Brodt, P., Fallavollita, L., Khatib, A-M., Samani, A., and Zhang, D. Cooperative regulation of the invasive/metastatic phenotype by different domains of the type I insulin like growth factor receptor β subunit. J. Biol. Chem., 276: 33608-33615, 2001.
16. Macaulay, V. M. Insulin-like growth factors and cancer. Br. J. Cancer, 65: 311-320, 1992.
17. Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., and Semenza, G. L. IGF-I induces HIF-1-mediated VEGF expression that is dependent on MAP kinase and PI-3-kinase signaling in colon cancer cells. J. Biol. Chem., 277: 38205-38211, 2002.
18. Brodt, P. Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities. Cancer Res., 46: 2442-2448, 1986.
19. Brodt, P. Tumor cell adhesion to frozen lymph node sections: an in vitro correlate of lymphatic metastasis. Clin. Exp. Metastasis, 7: 343-352, 1989.
20. Shestowsky, W., Fallavollita, L., and Brodt, P. A monoclonal antibody to Lewis lung carcinoma variant H-59 identifies a plasma membrane protein with apparent relevance to lymph node adhesion and metastasis. Cancer Res., 50: 1948-1953, 1990.
21. Long, L., Rubin, R., Baserga, R., and Brodt, P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res., 55: 1006-1009, 1995.
22. Butler, A. A., Yakar, S., Gewolb, I. H., Kams, M., Okubo, Y., and LeRoith, D. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 121: 19-26, 1998.
23. Petley, T., Graff, K., Jiang, W., Yang, H., and Florini, J. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm. Metab. Res., 31: 70-76, 1999.
24. Long, L., Rubin, R., and Brodt, P. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type I insulin-like growth factor receptor. Exp. Cell Res., 238: 116-121, 1998.
25. Enholm, B., Paavonen, K., Ristimaki, A., Kumar, V., Gunji, Y., Klefstrom, J., Kivinen, L., Laiho, M., Olofsson, B., Joukov, V., Eriksson, U., and Alitalo, K. Comparison of VEGF, VEGF-B, VEGF-C and Ang-I mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene, 14: 2475-2483, 1997.
26. Chilov, D., Kukk, E., and Taira, S. Genomic organization of human and mouse genes for vascular endothelial growth factor. C. J. Biol. Chem., 272: 25176-25183, 1997.
27. Ishibashi, H., Nakagawa, K., Onimaru, M., Castellanous, E. J., Kaneda, Y., Nakashima, Y., Shirasuna, K., and Sueishi, K. Spl decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor β1, and tissue factor and also cell growth and invasion activities. Cancer Res., 60: 6531-6536, 2000.
28. Qin, H., Sun, Y., and Benveniste, E. N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem., 274: 29130-29137, 1999.
29. Xie, W., Duan, R., and Safe, S. Activation of adenosine deaminase in MCF-7 cells through IGF-estrogen receptor α crosstalk. J. Mol. Endocrinol., 26: 217-228, 2001.
30. Valentinis, B., and Baserga, R. IGF-I receptor signalling in transformation and differentiation. Mol. Pathol., 54: 133-137, 2001.
31. Parrizas, M., Saltiel, A. R., and LeRoith, D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem., 272: 154-161, 1997.
32. Dufourny, B., Alblas, J., van Teeffelen, H. A., van Schaik, F. M., van der Burg, B., Steenbergh, P. H., and Sussenbach, J. S. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem., 272: 31163-31171, 1997.
33. Roudabush, F. L., Pierce, K. L., Maudsley, S., Khan, K. D., and Luttrell, L. M. Transactivation of the EGF receptor mediates IGF-I-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J. Biol. Chem., 275: 22583-22589, 2000.
34. Blakesley, V. A., Koval, A. P., Stannard, B. S., Scrimgeour, A., and LeRoith, D. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth. J. Biol. Chem., 273: 18411-18422, 1998.
35. Hermanto, U., Zong, C. S., Li, W., and Wang, L-H. RACKI, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol. Cell. Biol., 22: 2345-2365, 2002.
36. Kiely, P. A., Sant, A., and O'Connor, R. RACK1 is an insulin-like growth factor 1 (IGF-I) receptor-interacting protein that can regulate IGF-I-mediated Akt activation and protection from cell death J. Biol. Chem., 277: 22581-22589, 2002.
37. Ellis, M. J., Singer, C., Hornby, A., Rasmussen, A., and Cullen, K. J. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res. Treat., 31: 249-261, 1994.
38. LeBedis, C., Chen, K., Fallavollita, L., Boutros, T., and Brodt, P. Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int. J. Cancer, 100: 2-8, 2002.
39. Lopez, T., and Hanahan, D. Elevated levels of IGF-I receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell, 1: 339-353, 2002.